Systemic-onset juvenile idiopathic arthritis
MONDO:0019434Systemic-onset juvenile idiopathic arthritis is marked by the severity of the extra-articular manifestations (fever, cutaneous eruptions) and by an equal sex ratio.
Also known as: SoJIA, Still disease, sJIA, systemic polyarthritis, systemic-onset JIA, Still's disease (formerly), systemic juvenile idiopathic arthritis, systemic onset juvenile idiopathic arthritis
59 clinical trials for this condition and its sub-types, 25 tagged with Systemic-onset juvenile idiopathic arthritis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
New pill could ease arthritis in kids – major trial underway
Disease control OngoingThis study tests whether baricitinib, a daily pill, is safe and works for children aged 1 to under 18 with systemic juvenile idiopathic arthritis (sJIA), a chronic inflammatory disease. About 58 children will receive either baricitinib or a standard injected drug (tocilizumab) to…
Phase 3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Could a daily injection tame two rare inflammatory diseases?
Disease control CancelledThis study tests the drug anakinra in Chinese patients with two related inflammatory conditions: Systemic Juvenile Idiopathic Arthritis (SJIA) in children and Adult-Onset Still's Disease (AOSD) in adults. Participants receive a daily injection under the skin for 48 weeks. The goa…
Phase 4 • Sponsor: Swedish Orphan Biovitrum • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC